RECITALSRegistration Rights Agreement • April 4th, 2006 • Brainstorm Cell Therapeutics Inc • Biological products, (no disgnostic substances) • New York
Exhibit 10.4 THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD,...Brainstorm Cell Therapeutics Inc • April 4th, 2006 • Biological products, (no disgnostic substances) • Washington
EXHIBIT 10.3 CONSULTING AGREEMENT THIS CONSULTING AGREEMENT ("Agreement") is entered into as of the ___ day of July, 2004, by and between Golden Hand Resources, Inc., a company incorporated under the laws of the State of Washington, having its...Consulting Agreement • July 16th, 2004 • Golden Hand Resources Inc • Telegraph & other message communications
COMMON STOCK PURCHASE WARRANTBrainstorm Cell Therapeutics Inc. • July 19th, 2023 • Biological products, (no disgnostic substances)
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after ___, 2023 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on _________1 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Brainstorm Cell Therapeutics Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
Exhibit 10.13 BRAINSTORM CELL THERAPEUTICS INC. OPTION AGREEMENT Made effective as of the 31st day of December, 2004 BETWEEN: Brainstorm Cell Therapeutics Inc. A company incorporated in Washington (hereinafter the "Company")Option Agreement • April 1st, 2005 • Brainstorm Cell Therapeutics Inc • Biological products, (no disgnostic substances)
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 19th, 2023 • Brainstorm Cell Therapeutics Inc. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of _______ between Brainstorm Cell Therapeutics Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • June 13th, 2014 • Brainstorm Cell Therapeutics Inc. • Biological products, (no disgnostic substances)
This Registration Rights Agreement (this “Agreement”) is made and entered into as of June ___, 2014, between Brainstorm Cell Therapeutics Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
EXECUTION COPY THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD,...Brainstorm Cell Therapeutics Inc • August 10th, 2005 • Biological products, (no disgnostic substances) • New York
EMPLOYMENT AGREEMENT THIS AGREEMENT is entered into as of November 16, 2004 (the "EFFECTIVE DATE"), by and between BRAINSTORM CELL THERAPEUTICS LTD., a company incorporated under the laws of the State of Israel and maintaining its principal place of...Employment Agreement • November 22nd, 2004 • Golden Hand Resources Inc • Telegraph & other message communications • Tel-Aviv
THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR...Brainstorm Cell Therapeutics Inc • December 28th, 2004 • Telegraph & other message communications • Washington
RECITALSCommon Stock Purchase Agreement • October 28th, 2004 • Golden Hand Resources Inc • Telegraph & other message communications • Washington
COMMON STOCK PURCHASE WARRANT BRAINSTORM CELL THERAPEUTICS INC.Brainstorm Cell Therapeutics Inc. • January 8th, 2015 • Biological products, (no disgnostic substances)
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Initial Exercise Date (as set forth above) and on or prior to the close of business on June 19, 2018 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Brainstorm Cell Therapeutics Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
EMPLOYMENT AGREEMENT THIS AGREEMENT is entered into as of November 8, 2004 (the "Effective Date"), by and between BrainStorm Cell Therapeutics Ltd., a company incorporated under the laws of the State of Israel and maintaining its principal place of...Employment Agreement • November 9th, 2004 • Golden Hand Resources Inc • Telegraph & other message communications • Tel-Aviv
LICENSE AGREEMENT ------------------ THIS AGREEMENT MADE EFFECTIVE AND EXECUTED AS OF October 31, 2001 (the "Effective Date"). BETWEEN:License Agreement • May 7th, 2002 • Wizbang Technologies Inc • Telegraph & other message communications • Washington
AMENDMENT AGREEMENTAmendment Agreement • April 4th, 2006 • Brainstorm Cell Therapeutics Inc • Biological products, (no disgnostic substances)
RESTRICTED STOCK AWARD AGREEMENT UNDER THE BRAINSTORM CELL THERAPEUTICS INC. 2005 U.S. STOCK OPTION AND INCENTIVE PLAN Name of Grantee: Scientific Advisory Board Members No. of Shares: 100,000 Purchase Price per Share (if any): $0.00005 Grant Date:...Restricted Stock Award Agreement • August 10th, 2005 • Brainstorm Cell Therapeutics Inc • Biological products, (no disgnostic substances)
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 29th, 2012 • Brainstorm Cell Therapeutics Inc • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of _______ ___, 2012, between Brainstorm Cell Therapeutics Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR...Brainstorm Cell Therapeutics Inc • October 3rd, 2005 • Biological products, (no disgnostic substances) • New York
EXHIBIT 99 RESTRICTED STOCK PURCHASE AGREEMENT This is an agreement ("Agreement") between Mike Frankenberger ("Seller") and Irit Arbel ("Buyer") made this 28 day of April 2003. WHEREAS: A. Seller owns 2,300,000 shares (the "Shares") of Golden Hand...Exhibit 99 • June 9th, 2004 • Golden Hand Resources Inc • Telegraph & other message communications • Washington
COMMON STOCK PURCHASE WARRANT brainstorM cell therapeutics inc.Brainstorm Cell Therapeutics Inc • June 29th, 2012 • Biological products, (no disgnostic substances)
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the _____ year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Brainstorm Cell Therapeutics Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
COMMON STOCK PURCHASE WARRANT brainstorm cell therapeutics inc.Brainstorm Cell Therapeutics Inc. • August 6th, 2013 • Biological products, (no disgnostic substances) • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [_______] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the 30 month anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Brainstorm Cell Therapeutics Inc., a Delaware corporation (the “Company”), up to [_______] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is the Warrant to purchase Common Stock (this “Warrant”) issued pursuant to (i) the Underwriting Agreement, dated as of August [___], 2013, by and among the Company, Roth Capital Partners, LLC
AMENDMENT TO OPTION AGREEMENT The Option Agreement, dated as of March 29, 2005, between Mr. David Stolick and BrainStorm Cell Therapeutics Inc. (the "Option Agreement") is hereby amended as follows (capitalized terms used herein and not defined herein...Option Agreement • February 7th, 2006 • Brainstorm Cell Therapeutics Inc • Biological products, (no disgnostic substances)
EXHIBIT 4.10 THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD,...Brainstorm Cell Therapeutics Inc • December 12th, 2005 • Biological products, (no disgnostic substances) • New York
EXHIBIT 10.1Sale Agreement • September 19th, 2003 • Golden Hand Resources Inc • Telegraph & other message communications • British Columbia
BRAINSTORM CELL THERAPEUTICS INC.Underwriting Agreement • August 13th, 2013 • Brainstorm Cell Therapeutics Inc. • Biological products, (no disgnostic substances) • New York
Brainstorm Cell Therapeutics Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters named on Schedule I hereto (the “Underwriters,” or each, an “Underwriter”) an aggregate of 23,529,411 units (the “Firm Units”), each Firm Unit consisting of (i) one share (the “Firm Shares”) of common stock, par value $0.00005 per share (the “Common Stock”), of the Company and (ii) 0.75 of one warrant (the “Firm Warrants”) to purchase one share of Common Stock (the “Firm Warrant Shares”). The Firm Units are collectively referred to as the “Units”, the Firm Shares are collectively referred to as the “Shares” and the Firm Warrants are collectively referred to as the “Warrants”. The Units, the Shares, the Warrants and the Warrant Shares are collectively referred to as the “Securities”. The Shares and the Warrants shall be immediately separable and transferable upon issuance. The terms of the Warrants are set f
COMMON STOCK PURCHASE WARRANT BRAINSTORM CELL THERAPEUTICS INC.Brainstorm Cell Therapeutics Inc. • August 14th, 2024 • Biological products, (no disgnostic substances)
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after _____, 20241 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on _________20292 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Brainstorm Cell Therapeutics Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
EXHIBIT 10.1 RESTRICTED STOCK PURCHASE AGREEMENT This is an agreement ("Agreement") between Mike Frankenberger ("Seller") and Irit Arbel ("Buyer") made this 28 day of April 2003. WHEREAS: A. Seller owns 2,300,000 shares (the "Shares") of Golden Hand...Agreement • May 24th, 2004 • Golden Hand Resources Inc • Telegraph & other message communications • Washington
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • July 19th, 2023 • Brainstorm Cell Therapeutics Inc. • Biological products, (no disgnostic substances) • New York
DISTRIBUTION AGREEMENTDistribution Agreement • March 6th, 2020 • Brainstorm Cell Therapeutics Inc. • Biological products, (no disgnostic substances) • New York
Brainstorm Cell Therapeutics Inc., a Delaware corporation (the “Company”), confirms its agreement with Raymond James & Associates, Inc., as agent and/or principal under any Terms Agreement (as defined in Section 1(a) below) (“you,” the “Agent” or “Raymond James”), with respect to the issuance and sale from time to time by the Company, in the manner and subject to the terms and conditions described below in this Distribution Agreement (this “Agreement”), of common stock, $0.00005 par value per share (the “Common Stock”), of the Company having an aggregate Gross Sales Price (as defined in Section 2(b) below) of up to $50,000,000 (the “Maximum Amount”), subject to the limitations set forth in Section 2(h) hereof, on the terms set forth in Section 1 of this Agreement. Such shares are hereinafter collectively referred to as the “Shares” and are described in the Prospectus referred to below.
Exhibit 10.1 RESEARCH AND LICENSE AGREEMENT This License Agreement is entered into as of this 30th day of March, 2006 (the "Restated Effective Date"), by and between Brainstorm Cell Therapeutics Inc.(formerly Golden Hand Resources, Inc.), a company...Research and License Agreement • April 4th, 2006 • Brainstorm Cell Therapeutics Inc • Biological products, (no disgnostic substances)
COMMON STOCK PURCHASE WARRANT brainstorm cell therapeutics inc.Brainstorm Cell Therapeutics Inc. • August 13th, 2013 • Biological products, (no disgnostic substances) • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [_______] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the third anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Brainstorm Cell Therapeutics Inc., a Delaware corporation (the “Company”), up to [_______] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is the Warrant to purchase Common Stock (this “Warrant”) issued pursuant to (i) the Underwriting Agreement, dated as of August 13, 2013, by and among the Company, Roth Capital Partners, LLC and M
EXHIBIT 10.1 ------------ LICENSE AGREEMENT ----------------- THIS AGREEMENT MADE EFFECTIVE AND EXECUTED AS OF JUNE 10, 2002 (the "EffectiveLicense Agreement • November 14th, 2002 • Wizbang Technologies Inc • Telegraph & other message communications • Washington
Exhibit 10.2 SUBSCRIPTION AGREEMENT & INVESTMENT LETTER WIZBANG TECHNOLOGIES INC. To: Wizbang Technologies Inc. Suite 679, 185 - 911 Yates Street Victoria, British Columbia Canada V8V 4Y9 The Undersigned hereby subscribes for: 400,000 shares of Common...Subscription Agreement • June 18th, 2001 • Wizbang Technologies Inc • Telegraph & other message communications
pursuant to discussions with management of the Company regarding the specific business plans of the Company. The undersigned acknowledges that he fully understands that (i) the Company is a start-up company and is not currently conducting any business but does have specific business plans; (ii) following completion of its current financing, the Company will have approximately 9,600,000 shares of Common Stock issued and outstanding; and (iii) the Shares are being offered pursuant to an exemption from registration under Regulation S promulgated under the Securities Act of 1933, as amended (the "Act"). It is further acknowledged that the Undersigned: (i) is not relying upon any representations other than those specifically made by officers or representatives of the Company and (ii) has had access to the Company's officers and directors for purposes of obtaining any information requested by the Undersigned.
THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUED UPON ITS EXERCISE ARE SUBJECT TO THE RESTRICTIONS ON TRANSFER SET FORTH IN SECTION 4 OF THIS WARRANTBrainstorm Cell Therapeutics Inc. • May 13th, 2014 • Biological products, (no disgnostic substances) • Delaware
BrainStorm Cell Therapeutics, Inc., a Delaware corporation (the “Company”), for value received, hereby certifies that Hadasit Medical Research Services and Development Ltd., or its registered assigns (the “Registered Holder”), is entitled, subject to the terms and conditions set forth below, to purchase from the Company, at any time or from time to time on or after the date of issuance and on or before 5:00 p.m. (New York time) on April 13, 2024 (the “Expiration Date”), 33,334 shares of Common Stock, $0.00005 par value per share, of the Company, at a purchase price of $0.00005 per share. The shares purchasable upon exercise of this Warrant, and the purchase price per share, each as adjusted from time to time pursuant to the provisions of this Warrant, are hereinafter referred to as the “Warrant Shares” and the “Purchase Price,” respectively.
EXHIBIT 10.4 AGREEMENT --------- THIS AGREEMENT MADE EFFECTIVE AS OF April 7, 2004 (the "Effective Date"). BETWEEN: REACH TECHNOLOGIES, INC ----------------------- Suite 103 - 1581H Hillside Ave Victoria, B.C. V8T 2C1 ("REACH") AND: GOLDEN HAND...Agreement • June 14th, 2004 • Golden Hand Resources Inc • Telegraph & other message communications • Washington
